Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis

被引:87
|
作者
Jagels, MA
Travis, J
Potempa, J
Pike, R
Hugli, TE
机构
[1] UNIV GEORGIA, DEPT BIOCHEM, ATHENS, GA 30602 USA
[2] JAGIELLONIAN UNIV, INST MOLEC BIOL, DEPT MICROBIOL & IMMUNOL, KRAKOW, POLAND
[3] UNIV NATAL, DEPT BIOCHEM, PIETERMARITZBURG 3200, SOUTH AFRICA
关键词
D O I
10.1128/IAI.64.6.1984-1991.1996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The anaerobic bacterium Porphyromonas gingivalis has been implicated as a primary causative agent in adult periodontitis, Several proteinases are produced by this bacterium, and it is suggested that they contribute to virulence and to local tissue injury resulting from infection by P. gingivalis. Cysteine proteinases with specificities to cleave either Arg-X or Lys-X peptide bonds (i.e., gingipains) have been characterized as predominant enzymes associated with vesicles shed from the surface of this bacterium. It has recently been demonstrated that these proteinases are capable of degrading the blood complement component C5, resulting in the generation of biologically active C5a. By using an affinity-purified rabbit antibody raised against residues 9 to 29 of the C5a receptor (C5aR; CD88), we demonstrate that noncysteinyl proteinases associated with vesicles obtained from P. gingivalis cleave the C5aR on human neutrophils, Proteolytic attack of the C5aR by enzymes from the P. gingivalis vesicles was inhibited by TPCK (tolylsulfonyl phenylalanyl chloromethyl ketone), PMSF (phenylmethylsulfonyl fluoride), and dichloroisocoumarin, suggesting that serine proteinases are primarily responsible for this degradative activity. The purified vesicle proteinase Lys-gingipain but not Arg-gingipain also cleaved the N-terminal region of the C5aR on the human neutrophils. Lys-gingipain activity was essentially resistant to these inhibitors but was inhibited by TLCK (N alpha-p-tosyl-L-lysine chloromethyl ketone) and iodoacetamide. A synthetic peptide that mimics the N-terminal region of C5aR (residues 9 to 29; PDYGHY DDKDTLDLNTPVDKT) was readily cleaved by chymotrypsin but not by trypsin, despite the presence of two potential trypsin (i.e., lysyl-X) cleavage sites. The specific sites of cleavage in the C5aR 9-29 peptide were determined by mass spectroscopy for both chymotrypsin and Lys-gingipain digests. This analysis demonstrated that the C5aR peptide is susceptible to cleavage at both potential Lys-gingipain sites (i.e., between residues 17 and 18 [K-D] and 28 and 29 [K-T]) and at two chymotrypsin sites (between residues 14 and 15 [Y-D] and 20 and 21 [L-D]), respectively. These studies suggest that P, gingivalis contains at least two enzymes capable of cleaving the C5aR, Lys-gingipain and a second nontryptic serine proteinase that is distinct from either Arg- or Lys-gingipain.
引用
收藏
页码:1984 / 1991
页数:8
相关论文
共 50 条
  • [41] Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor
    Nikiforovich, Gregory V.
    Marshall, Garland R.
    Baranski, Thomas J.
    BIOCHEMISTRY, 2008, 47 (10) : 3117 - 3130
  • [42] Neuronal expression of the C5a receptor
    O'Barr, S
    Yu, JX
    Cooper, NR
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 337 - 337
  • [43] The Alternative C5a Receptor Function
    Nishiura, Hiroshi
    COMPLEMENT THERAPEUTICS, 2013, 735 : 111 - 121
  • [44] Gut flora alterations due to lipopolysaccharide derived from Porphyromonas gingivalis
    Nodoka Sugiyama
    Osamu Uehara
    Tetsuro Morikawa
    Durga Paudel
    Kazuma Ebata
    Daichi Hiraki
    Fumiya Harada
    Koki Yoshida
    Satsuki Kato
    Toshiyuki Nagasawa
    Hiroko Miura
    Yoshihiro Abiko
    Yasushi Furuichi
    Odontology, 2022, 110 : 673 - 681
  • [45] Thrombospondin-1 receptors regulate leukocyte chemotactic response to C5a/C5a des Arg
    Ge, Lingyin
    Trujillo, Glenda
    Zhang, Jianhua
    Kew, Richard R.
    MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2282 - 2282
  • [46] Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo
    Hetland, G
    Moen, O
    Bergh, K
    Hogasen, K
    Hack, CE
    Mollnes, TE
    Fosse, E
    ANNALS OF THORACIC SURGERY, 1997, 63 (04): : 1076 - 1080
  • [47] C5A PENTAPEPTIDE RECEPTOR LIGANDS
    OR, YS
    CLARK, RF
    LANE, B
    MOLLISON, KW
    CARTER, GW
    LULY, JR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 117 - MEDI
  • [48] TETRAHYDROIMIDAZOPYRIDINES AS LIGANDS FOR THE C5A RECEPTOR
    KIM, D
    RIVERO, RA
    DELASZLO, SE
    TRAN, J
    FAIR, J
    ASHTON, WT
    HUTCHINS, SM
    MALKOWITZ, L
    MOLINEAUX, C
    SICILIANO, S
    SPRINGER, MS
    GREENLEE, WJ
    MANTLO, NB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 86 - MEDI
  • [49] Nonpeptidic C5a receptor antagonists
    不详
    DRUG DISCOVERY TODAY, 1997, 2 (07) : 303 - 303
  • [50] Gut flora alterations due to lipopolysaccharide derived from Porphyromonas gingivalis
    Sugiyama, Nodoka
    Uehara, Osamu
    Morikawa, Tetsuro
    Paudel, Durga
    Ebata, Kazuma
    Hiraki, Daichi
    Harada, Fumiya
    Yoshida, Koki
    Kato, Satsuki
    Nagasawa, Toshiyuki
    Miura, Hiroko
    Abiko, Yoshihiro
    Furuichi, Yasushi
    ODONTOLOGY, 2022, 110 (04) : 673 - 681